WOLVERINE 10mg Blend
- ≥99% purity by HPLC
- Janoshik COA with every lot
- Lot-traceable from synthesis
- EU-synthesised
Specifications
Third Party Lab Tested
Every lot is independently HPLC-tested by Janoshik Analytical, Europe's reference laboratory for peptide purity assessment. The COA shipped with your order is theirs, not ours.
Storage & Handling
Lyophilized peptides should be stored below 16°C, protected from light and moisture, for up to 24 months. Once reconstituted, refrigerate and use within 30 days for protocol consistency.
Reconstitution
Reconstitute with bacteriostatic water using the volumes below. Add solvent slowly along the inside wall of the vial. Swirl gently, never shake, until fully dissolved.
Lab-handling protocol BAC Water · 0.9% benzyl alcohol The reconstitution solvent referenced above. Add to order →Two peptides. Two research pathways.
WOLVERINE is a defined 10 MG research blend containing BPC-157 5 MG and TB-500 5 MG. BPC-157 is a 15-amino-acid gastric pentadecapeptide analogue, while TB-500 is a synthetic fragment associated with thymosin beta-4 research. The equal-mass blend combines two distinct peptide entities studied in cell-migration, angiogenesis and tissue-model literature.
The formulation is supplied as a lyophilized vial alongside the single-compound BPC-157 research peptide and the three-component GLOW blend. Each NZM-Labs lot is independently analysed by HPLC and mass spectrometry with lot-specific documentation. Note that NZM peptides are for laboratory research only.
| Compound 1 | BPC-157 · 5 MG |
|---|---|
| Compound 2 | TB-500 · 5 MG |
| Mechanism / research class | Dual research-peptide blend |
| Example laboratory preparation | 10 MG blend vial with 2 mL bacteriostatic water (0.9% benzyl alcohol) |
| Calculated concentration | BPC-157 2.5 mg and TB-500 2.5 mg per 1.0 mL |
| Supply format | WOLVERINE · 10 MG blend lyophilized research vial |
| Storage, lyophilized | store below 16°C for up to 24 months |
| Storage, reconstituted | refrigerate and use within 30 days |
Synthesised.
Verified.
Documented.
Backed by research.
Measured in results.
Each tag opens the cited literature behind that effect. References are linked to PubMed.
WOLVERINE pairs BPC-157's structural-protection profile with TB-500's actin-sequestration / migration profile. The combined-mechanism stack is the most-cited starting point in published recovery-protocol research, with documented effects on tendon, ligament, and gut-tissue repair models.
TB-500's actin-sequestration mechanism modulates endothelial cell migration and angiogenic response. Combined with BPC-157's vascular effects, the blend addresses both structural and vascular repair pathways in parallel.
- Sosne G et al. Thymosin β4 promotes angiogenesis. Ann NY Acad Sci. 2010;1194:114-118. PubMed ↗
Both compounds individually show anti-inflammatory activity in research models. BPC-157's literature includes direct effects on NO-pathway and prostaglandin signaling; TB-500 modulates inflammatory-cell recruitment via actin-cytoskeleton effects.
- Sikiric P et al. BPC-157 and inflammation. Curr Pharm Des. 2018;24(18):1990-2001. PubMed ↗
Questions?
We have answers.
No reviews yet
Write a review
Share your experience with WOLVERINE 10mg Blend. Reviews are published after a manual check.